Please select the option that best describes you:
Topics:
Hematologic Malignancies • Medical Oncology • Bone Marrow Transplant • Lymphoma • Internal Medicine • Hematology
What is your approach to treating relapsed subcutaneous panniculitis-like T-cell lymphoma?
Does it differ from the treatment of other relapsed peripheral T-cell lymphomas?
Are there any clinical trials or case series focused on SPTCL?
Is there data to guide the choice between consolidative autologous vs allogeneic HCT for SPTCL in CR2?
Answer from: Medical Oncologist at Academic Institution
Over the years the SPTL has been characterized better and the latest WHO lists it under PTCL with an α/β T-cell phenotype (SPTL-AB) and this has to be distinguished from primary cutaneous TCL with a γδ T-cell phenotype (PTCL-GD). Since they are so rare a workshop of the multid...
Sign in or Register to read more